Milton Mayo Morris, a director at $NDSN, sold 265 shares of the company on 11-03-2025 for an estimated $61,215. We received data on the trade from a recent SEC filing. This was a sale of approximately 8.4% of their shares of this class of stock. Following this trade, they now own 2,901 shares of this class of $NDSN stock.
$NDSN Insider Trading Activity
$NDSN insiders have traded $NDSN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $NDSN stock by insiders over the last 6 months:
- JOSEPH P KELLEY (Executive Vice President) sold 2,200 shares for an estimated $528,000
- MILTON MAYO MORRIS sold 265 shares for an estimated $61,215
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NDSN Hedge Fund Activity
We have seen 277 institutional investors add shares of $NDSN stock to their portfolio, and 304 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VAN ECK ASSOCIATES CORP added 762,014 shares (+inf%) to their portfolio in Q2 2025, for an estimated $163,352,941
- MILLENNIUM MANAGEMENT LLC added 360,600 shares (+6841.2%) to their portfolio in Q2 2025, for an estimated $77,301,822
- NEUBERGER BERMAN GROUP LLC removed 356,320 shares (-77.7%) from their portfolio in Q2 2025, for an estimated $76,384,318
- UBS GROUP AG added 292,018 shares (+134.6%) to their portfolio in Q2 2025, for an estimated $62,599,898
- BOWEN HANES & CO INC removed 194,920 shares (-98.8%) from their portfolio in Q2 2025, for an estimated $41,785,000
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC removed 157,041 shares (-5.9%) from their portfolio in Q2 2025, for an estimated $33,664,879
- STATE STREET CORP added 133,229 shares (+4.7%) to their portfolio in Q2 2025, for an estimated $28,560,300
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NDSN Analyst Ratings
Wall Street analysts have issued reports on $NDSN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 07/15/2025
- Oppenheimer issued a "Outperform" rating on 05/30/2025
To track analyst ratings and price targets for $NDSN, check out Quiver Quantitative's $NDSN forecast page.
$NDSN Price Targets
Multiple analysts have issued price targets for $NDSN recently. We have seen 3 analysts offer price targets for $NDSN in the last 6 months, with a median target of $252.0.
Here are some recent targets:
- Christopher Glynn from Oppenheimer set a target price of $275.0 on 08/25/2025
- Michael Halloran from Baird set a target price of $252.0 on 08/22/2025
- Jeffrey Hammond from Keybanc set a target price of $250.0 on 07/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
